Although results at individual time points were variable, more
consistent effects were obtained when examining efficacy across
the entire 12-month follow-up period. Fig. 2 depicts scatter plots of
the percentage of participants’ follow-ups at each criterion (100%,
90%, and 50% reduction) as a function of their fat preference
score. The correlation between the percentage of seizure-free
follow-ups and fat preference score was significant (rs[28] = .308,
p = .048), as was the correlation with follow-ups with 90%
reduction (rs[28] = .368, p = .023). Fat preference was not significantly correlated with percentage of checks with 50% reduction
(rs[28] = .170, p = .183)